Kiora Pharmaceuticals Inc · Brief

Next report

2 days

Nov 6 · before openest.Q3 FY26

Expected move

No implied move.

—≥ implied

Q2 FY26—▲+3.13%—

quarterimplied−5%0+5%realized×

Q2 FY26—▲+3.13%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 6 report · est.

—

KPRX report session

No linked exposure.

Oct 298-KMaterial agreement: Exclusive License Agreement with Senju Pharmaceutical Co., Ltd.Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.